GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Brightspring Health Services BTSG · USD

Health Care · US listing · 🇺🇸 United States

Compare

69.15

+2.98%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$12.91bn

FY2018FY2025

Net income

$190.7m

FY2018FY2025

Free cash flow

$394.7m

FY2018FY2025

Shareholders' equity

$1.88bn

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$12.91bn$11.27bn$8.83bn$7.72bn$6.70bn$5.58bn$4.53bn$2.54bn
Gross profit$1.52bn$1.59bn$1.43bn$1.35bn$1.25bn$1.05bn$833.9m$375.9m
Operating income$295.3m$206.4m$147.2m$187.8m$234.2m$165.2m$63.3m$74.8m
Net income$190.7m−$18.1m−$154.6m−$53.9m$49.8m$20.8m−$72.4m−$7.6m
Diluted earnings per share0.87-0.08-0.90-0.310.290.12-0.50-0.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets$6.41bn$5.93bn$5.53bn$5.44bn$5.51bn$4.54bn$3.82bn—
Cash and short-term investments$88.4m$61.3m$13.1m$13.6m$46.7m$262.0m$18.3m—
Total liabilities$4.53bn$4.27bn$4.92bn$4.66bn$4.71bn$3.81bn$3.11bn—
Debt$2.56bn$2.65bn$3.40bn$3.43bn$3.46bn$2.72bn$2.21bn—
Shareholders' equity$1.88bn$1.65bn$584.7m$754.8m$774.8m$705.0m$656.9m—
Shares outstanding218m213m171m171m171m171m144m171m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations$490.2m$23.8m$210.8m−$4.7m$270.2m$222.6m$110.9m$76.5m
Capital spending−$95.5m−$80.9m−$73.5m−$70.1m−$59.3m−$51.9m−$51.2m−$33.2m
Free cash flow$394.7m−$57.1m$137.3m−$74.8m$210.9m$170.7m$59.7m$43.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$3.87bn$3.61bn$3.55bn$3.33bn$3.15bn$2.88bn$3.05bn$2.91bn
Gross profit$492.7m$482.2m$412.5m$392.0m$374.9m$338.4m$421.9m$408.1m
Operating income$144.6m$137.6m$108.1m$87.8m$48.6m$50.7m$79.1m$56.8m
Net income$86.7m$74.4m$77.1m$55.8m$28.2m$29.5m$16.0m−$8.2m
Diluted earnings per share0.390.340.350.260.130.140.08-0.04
Cash from operations$43.0m$122.0m$231.0m$107.0m$49.0m$101.0m$90.0m$27.0m
Capital spending−$29.0m−$21.0m−$37.0m−$15.0m−$24.0m−$17.0m−$15.0m−$20.0m
Free cash flow$14.0m$101.0m$194.0m$92.0m$25.0m$84.0m$75.0m$7.0m
Total assets$5.99bn$6.21bn$6.41bn$6.05bn$5.94bn$5.85bn$5.93bn$5.79bn
Cash and short-term investments$550.4m$888.8m$88.4m$140.3m$70.1m$52.3m$61.3m$36.0m
Debt$2.24bn$2.55bn$2.56bn$2.56bn$2.57bn$2.58bn$2.69bn$2.74bn
Shareholders' equity$2.05bn$1.98bn$1.88bn$1.82bn$1.74bn$1.69bn$1.65bn$1.61bn

Financial ratios

Data as of 11 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin11.8%14.1%16.2%17.5%18.6%18.8%
Operating margin2.3%1.7%1.7%2.4%3.5%3.0%
Net margin1.5%-0.2%-1.8%-0.7%0.7%0.4%
Return on equity10.2%-1.1%-26.4%-7.1%6.4%3.0%
Return on assets3.0%-0.3%-2.8%-1.0%0.9%0.5%
Free cash flow yield4.2%0.8%2.6%0.6%3.0%2.5%
Revenue growth14.6%27.6%14.3%15.3%20.0%23.3%
Earnings growth-1155.6%-88.3%186.8%-208.2%139.3%-128.8%
Current ratio1.57x1.33x1.17x1.44x1.32x1.74x
Debt to equity1.36x1.63x5.89x4.60x4.54x3.92x
Equity ratio29.2%27.8%10.6%13.9%14.1%15.5%
Interest coverage1.88x0.85x0.45x0.80x1.42x1.19x
Buybacks as a share of market value-2.5%-24.5%0.0%0.0%0.0%-18.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.7%18.3%—
Operating income16.3%12.3%—
Net income—55.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin12.8%14.5%15.5%—
Operating margin2.1%2.1%2.3%—
Net margin0.7%-0.1%0.1%—

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings42.9-201.0
Price to sales0.60.3

Market value over time

31 Jan 2024 to 9 Oct 2026, in USD

$1.30bn$14.04bn

Share price return

Finished calendar years

20252024
Return114%56%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.